Response‐adaptive randomization for survival trials: the parametric approach

Few references deal with response-adaptive randomization procedures for survival outcomes and those that do either dichotomize the outcomes or use a non-parametric approach. In this paper, the optimal allocation approach and a parametric response-adaptive randomization procedure are used under exponential and Weibull distributions. The optimal allocation proportions are derived for both distributions and the doubly adaptive biased coin design is applied to target the optimal allocations. The asymptotic variance of the procedure is obtained for the exponential distribution. The effect of intrinsic delay of survival outcomes is treated. These findings are based on rigorous theory but are also verified by simulation. It is shown that using a doubly adaptive biased coin design to target the optimal allocation proportion results in more patients being randomized to the better performing treatment without loss of power. We illustrate our procedure by redesigning a clinical trial. Copyright 2007 Royal Statistical Society.

[1]  William F. Rosenberger,et al.  Randomization in Clinical Trials , 2003 .

[2]  J. Lawless Statistical Models and Methods for Lifetime Data , 2002 .

[3]  Lee-Jen Wei,et al.  Play the winner for phase II/III clinical trials. , 1996, Statistics in medicine.

[4]  W F Rosenberger,et al.  Adaptive survival trials. , 1997, Journal of biopharmaceutical statistics.

[5]  Atanu Biswas,et al.  Optimal Adaptive Designs in Phase III Clinical Trials for Continuous Responses with Covariates , 2004 .

[6]  Connie Page,et al.  An adaptive randomized design with application to estimation , 2001 .

[7]  William F. Rosenberger,et al.  Optimality, Variability, Power , 2003 .

[8]  William F. Rosenberger,et al.  Implementing Optimal Allocation in Sequential Binary Response Experiments , 2007 .

[9]  Feifang Hu,et al.  Asymptotic properties of doubly adaptive biased coin designs for multitreatment clinical trials , 2003 .

[10]  B. Overmoyer,et al.  Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Jerald F. Lawless,et al.  Statistical Models and Methods for Lifetime Data: Lawless/Statistical , 2002 .

[12]  William F Rosenberger,et al.  Response‐Adaptive Randomization for Clinical Trials with Continuous Outcomes , 2006, Biometrics.

[13]  N Stallard,et al.  Optimal Adaptive Designs for Binary Response Trials , 2001, Biometrics.

[14]  A Hallstrom,et al.  Logrank, play the winner, power and ethics. , 1996, Statistics in medicine.